Aegis Capital Starts Nektar Therapeutics (NKTR) at Buy

November 8, 2016 8:47 AM EST
Get Alerts NKTR Hot Sheet
Price: $12.02 -1.88%

Rating Summary:
    11 Buy, 1 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade NKTR Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Aegis Capital initiated coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy rating and a price target of $21.00.

For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.

Shares of Nektar Therapeutics closed at $12.80 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Add Your Comment